Production assistance for cellular therapies (pact)- cell processing facilities cell manufacturing and process development services for PCT0005-02: cryopreservation technical study
Ended Awarded Last action
- Contract number
- 75N92019F00036
- Awardee
-
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. UEI DVHKP4N619V9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $211,273
Award facts
- Opportunity
-
- 75N92018R0069 Solicitation number
- Contract value 100% obligated
- $211,273.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Tampa, FL 33612, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Supplemental Agreement for work within scope | -$30,869 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $242,142 |
About this award
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., a non-profit, National Cancer Institute-designated comprehensive cancer center located in Tampa, Florida, was awarded a delivery order contract valued at $211,273.45 by the National Heart Lung and Blood Institute on December 3, 2018. This contract falls under the Production Assistance for Cellular Therapies – Cell Processing Facilities (PACT-CPF) master indefinite delivery, indefinite quantity vehicle and specifically supports cell manufacturing and process development services for a cryopreservation technical study (PCT0005-02). The contract carries a cost-plus-no-fee pricing structure with no small business set-aside designation and was set to conclude by June 2, 2020.
The engagement leverages Moffitt's established expertise in advanced medical research and specialized laboratory services to support the federal government's cellular therapy initiatives. As a leading research facility with experience in translational medicine, immunotherapy, and precision medicine, Moffitt is positioned to contribute technical expertise in cryopreservation processes—a critical capability for preserving and processing cellular therapies. The work performed at the Tampa, Florida facility contributes to the broader PACT-CPF program's objectives of advancing cellular therapy manufacturing capabilities and standardized processes within the federal research infrastructure.
Quick answers
Who was awarded contract 75N92019F00036?
75N92019F00036 was awarded to H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on December 3, 2018.
How much is contract 75N92019F00036 worth?
The government has obligated $211,273 on 75N92019F00036.
Is contract 75N92019F00036 an order under another contract?
Yes. 75N92019F00036 is a delivery order under HHSN268201600013I, an indefinite delivery contract, on Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF).
Was contract 75N92019F00036 competed?
The extent of competition for 75N92019F00036 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award